A patch for Parkinson's

Schwarz Pharma AG's Neupro rotigotine dopamine receptor agonist for Parkinson's disease may have an advantage over marketed compounds in the same class because it is administered once daily using a patch. By comparison, marketed dopamine receptor agonists are dosed orally three times daily.

Schwarz reported

Read the full 444 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE